Total Funding
40
76
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
57567
Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.
- Gregory Moe: Chief Scientific Advisor & Co-Founder
- Sherry Martin-Moe: President & Co-Founder
About the Company
Saccharo is a biotech start-up in the immuno-oncology space that develops therapeutic products for the treatment of cancer and other novel diseases.
Saccharo discovered a polysaccharide that surrounds human cancer cells. The Sacchario approach has a mechanism of action that allows drugs to have multiple killing effects, a predicted safety
profile, a broad therapeutic window, and applications to many cancers.
Saccharo was established in 2017 by Sherry Martin-Moe and Gregory Moe in Oakland, California.
Women Founded
